Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
National Vaccine and Serum Institute · Chinese Center For Disease Control and Prevention · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
801
total citations
- FWCI
- 17.94
- Percentile
- 100%
- References
- 27
Citations per year
Authors
32- HWHui WangCorresponding
National Vaccine and Serum Institute
- YZYuntao Zhang
National Vaccine and Serum Institute
- BHBaoying Huang
Chinese Center For Disease Control and Prevention, National Institute for Viral Disease Control and Prevention
- WDWei Deng
Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Laboratory Animal Science
- YQYaru Quan
National Institutes for Food and Drug Control
Topics & keywords
Topics
Keywords
- Biology
- Virology
- Pandemic
- Neutralizing antibody
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Antibody
- Immunology
- Coronavirus disease 2019 (COVID-19)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.